Hofseth Biocare ASA (HOFBF) Income Statement
Hofseth Biocare ASA Income Statement
Last quarter (Q1 2026), Hofseth Biocare ASA's total revenue was $48.79M, a decrease of 28.71% from the same quarter last year. In Q1, Hofseth Biocare ASA's net income was $-36.57M. See Hofseth Biocare ASA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 254.43M | $ 257.42M | $ 194.87M | $ 120.45M | $ 87.62M | |
| $ -32.47M | $ 87.86M | $ 44.19M | $ 28.51M | $ 23.10M | |
| $ 80.22M | $ 96.47M | $ 146.72M | $ 157.13M | $ 141.66M | |
| Depreciation and Amortization | $ 39.41M | $ 39.78M | $ 36.41M | $ 30.22M | $ 29.35M |
| $ -73.28M | $ -62.35M | $ -62.73M | $ -97.21M | $ -87.72M | |
| $ -112.69M | $ -113.98M | $ -102.53M | $ -128.62M | $ -118.56M | |
| $ -22.02M | $ -11.31M | $ -4.16M | $ -8.77M | $ -7.90M | |
| $ -134.71M | $ -125.30M | $ -106.68M | $ -137.39M | $ -126.46M | |
| $ -134.88M | $ -123.41M | $ -106.68M | $ -137.39M | $ -126.46M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.33 | $ -0.30 | $ -0.27 | $ -0.37 | $ -0.35 |
| Diluted EPS | $ -0.33 | $ -0.30 | $ -0.27 | $ -0.37 | $ -0.35 |
| Weighted Average Shares Outstanding | 411.08M | 411.08M | 395.08M | 374.74M | 357.83M |
| Weighted Average Shares Outstanding (Diluted) | 411.08M | 412.17M | 395.08M | 374.74M | 357.83M |
Currency in NOK